drugset / Trial / NCT00331149

A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's

NCT00331149

Phase 3 Completed 343 enrolled GlaxoSmithKline
RandomizedParallel-groupTreatment

Summary

This study was designed to compare the effectiveness and tolerability of a new prolonged release formulation of ropinirole with the currently marketed immediate release formulation which is prescribed in many countries. The new prolonged release formulation allows the drug to be taken once a day rather than three times a day. This study will also evaluate the side effects of the new prolonged release formulation of ropinirole

Timeline

Start
2006-06-20
Primary completion
2007-08-29
Completion
2007-08-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropinirole Small molecule

Indications